In Cancer Patients, PTSD May Increase Symptom Burden

Share this content:
In Cancer Patients, PTSD May Increase Symptom Burden
In Cancer Patients, PTSD May Increase Symptom Burden

TUESDAY, June 26, 2018 (HealthDay News) -- Post-traumatic stress disorder (PTSD) symptoms among hospitalized patients with cancer are associated with a greater psychological and physical symptom burden as well as a decreased risk of hospital readmissions, according to a study published online June 15 in Cancer.

Ryan D. Nipp, M.D., M.P.H., from Massachusetts General Hospital Cancer Center in Boston, and colleagues explored relationships among PTSD symptoms, physical and psychological symptom burden, and risk for hospital readmissions among 954 prospectively enrolled patients with cancer admitted for an unplanned hospitalization from August 2015 to April 2017.

The researchers found that 13.3 percent of patients screened positive for PTSD symptoms. The 90-day hospital readmission rate was 38.9 percent. Higher PTSD scores were seen among patients with younger age, female sex, greater comorbidities, and genitourinary cancer type. There was an association between patients' PTSD symptoms and physical symptoms, total symptom burden, depression, and anxiety symptoms. PTSD symptoms were associated with a lower risk of hospital readmissions (hazard ratio, 0.81).

"Interventions to address patients' PTSD symptoms are needed and should account for their physical and psychological symptom burden," write the authors.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »